Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: Disease activity resumes after stopping treatment

Neurology

Volumn 47, Issue 1, 1996, Pages 123-129

  Durelli, L ^a   Bongioanni, M R ^a   Ferrero, B ^a   Ferri, R ^a   Imperiale, D ^a   Bradac, G B ^a   Bergui, M ^a   Geuna, M ^a   Bergamini, L ^a   Bergamasco, B ^a  

^a Clinica Neurologica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0030054701     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.1.123     Document Type: Article

References (0)